SG3 Management’s Exelixis EXEL Stock Holding History

SG3 Management’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-28,500	Closed	-$447K	–	252
2022 Q3	$447K	Buy	+28,500	New	+$551K	0.06%	149
2022 Q2	–	Sell	-35,000	Closed	-$793K	–	535
2022 Q1	$793K	Buy	+35,000	New	+$684K	0.02%	507
2021 Q2	–	Sell	-30,000	Closed	-$678K	–	1113
2021 Q1	$678K	Buy	30,000 +15,000	+100%	+$339K	0.02%	697
2020 Q4	$301K	Buy	+15,000	New	+$314K	0.01%	810

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SG3 Management's EXEL Position: Q4 2022 in Review

SG3 Management sold out of Exelixis (EXEL) in Q4 2022, closing a stake of 25,000 shares — an estimated $392K sold.

SG3 Management first reported a position in EXEL in Q4 2016 and held it in 2 quarters. The position peaked at $392K in Q3 2022. 386 funds tracked by Wall St. Rank hold EXEL as of Q4 2022.

SG3 Management reported no remaining Exelixis position as of Q4 2022 after selling out during the quarter.
SG3 Management sold 25,000 Exelixis shares in Q4 2022, an estimated $392K.
SG3 Management first reported a position in Exelixis in Q4 2016 and held it in 2 quarters.
SG3 Management's Exelixis position peaked at $392K in Q3 2022.
386 funds tracked by Wall St. Rank held Exelixis as of Q4 2022.

Based on SG3 Management's 13F filing for Q4 2022, filed 14 Feb 2023.